Omega Diagnostics secures distributors for VISITECT CD4

By
0 mins. to read
Omega Diagnostics secures distributors for VISITECT CD4
Master Investor Magazine 40 cover

Never miss an issue of Master Investor Magazine – sign-up now for free!

Read the latest Master Investor Magazine

Omega Diagnostics (LON:ODX) has announced the appointment of three new dedicated distributors in Ghana, Zambia and Zimbabwe for its VISITECT CD4 HIV test. All three countries require product registration, which has also commenced. Once completed, this will allow business to business sales to commence through the Company’s distributors.

“I am pleased to see our commercialisation plan for CD4 taking shape as this is key part of our strategy to delivering shareholder value,” commented Omega CEO Colin King. “This also provides further evidence that our CD4 test (the world’s first true point-of-care test) will make a significant difference to people living with HIV in resource-poor environments.”

Omega shares rose 0.7p on the news, to 15.7p (as at 09:47 BST).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

YOUR FREE INVESTMENT MAG

Get real investment insights from some of the best minds in the business - with our free Master Investor Magazine.